Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash from Operations (2020 - 2025)

Bioventus (BVS) has disclosed Cash from Operations for 6 consecutive years, with 37968000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 96.5% year-over-year to 37968000.0, compared with a TTM value of 74673000.0 through Dec 2025, up 92.48%, and an annual FY2025 reading of 74673000.0, up 92.48% over the prior year.
  • Cash from Operations was 37968000.0 for Q4 2025 at Bioventus, up from 30098000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 37968000.0 in Q4 2025 and bottomed at 21019000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 7019800.0, with a median of 9260500.0 recorded in 2023.
  • Peak annual rise in Cash from Operations hit 267.3% in 2023, while the deepest fall reached 5362.66% in 2023.
  • Year by year, Cash from Operations stood at 13117000.0 in 2021, then crashed by 50.33% to 6515000.0 in 2022, then rose by 25.94% to 8205000.0 in 2023, then soared by 135.49% to 19322000.0 in 2024, then surged by 96.5% to 37968000.0 in 2025.
  • Business Quant data shows Cash from Operations for BVS at 37968000.0 in Q4 2025, 30098000.0 in Q3 2025, and 25938000.0 in Q2 2025.